Oncotarget Genetic Alterations in Thyroid Cancer: Resistance to BRAFi and Anaplastic Transformation In this new research perspective, researchers discuss the role of genetic alterations in resistance to... read more February 8, 2024
Oncotarget New Drug May Boost Effectiveness of Glioblastoma Treatment In a new study, researchers investigated the activity of gartisertib, a potent ATR inhibitor, alone... read more January 25, 2024
Oncotarget How Osteopontin Stimulates Mitochondrial Biogenesis and Cancer Metastasis In this new study, researchers investigated the role of Osteopontin splice variants in cancer metastasis.—... read more January 11, 2024
Oncotarget Melatonin in Cancer Therapy: Lessons From 50 Years of Research In a new research perspective, researchers discuss melatonin's effects on cancer and the key importance... read more December 28, 2023
Oncotarget Triple Combination Treatment Overcomes Colorectal Cancer Resistance In a new study, researchers aimed to elucidate the role of cancer stemness in the... read more December 14, 2023
Oncotarget Can Mechanisms of Hair Loss Shed Light on Cancer and Aging? In a 2023 study, researchers investigated hair loss and their findings may lead to a... read more November 29, 2023
Oncotarget Immunotherapy Response in Primary vs Metastatic Pancreatic Cancer In this editorial, researchers delve into the immunotherapeutic challenges posed by the tumor microenvironment and... read more November 16, 2023
Oncotarget p53’s Protective Role in Extrahepatic Biliary Precancerous Lesions In this editorial, researchers from Japan discuss their recent study investigating the role of p53... read more November 2, 2023
Oncotarget How a Metabolic Enzyme Can Trigger Cell Death in Liver Cancer Cells In a new editorial paper, researchers highlight the role of GLS2 in regulating ferroptosis in... read more October 19, 2023
Oncotarget Genetic Insights into Early Breast Cancer in Kazakhstan In this new study, researchers aimed to determine the genetic predisposition to early breast cancer... read more October 5, 2023